Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.68%
1,098.83
-7.53
-0.68%
1,106.361,105.681,109.291,096.52
SIXC
Communications
SIXC
Communications
SIXC
+0.74%
614.82
+4.53
+0.74%
610.29610.29614.86610.29
SIXE
Energy
SIXE
Energy
SIXE
-0.07%
1,210.32
-0.90
-0.07%
1,211.221,211.011,220.571,208.50
SIXI
Industrials
SIXI
Industrials
SIXI
+0.12%
1,752.88
+2.17
+0.12%
1,750.711,753.101,762.131,743.30
SIXM
Financials
SIXM
Financials
SIXM
+0.85%
633.52
+5.35
+0.85%
628.17629.38633.75629.38
SIXR
Staples
SIXR
Staples
SIXR
+0.35%
857.58
+3.01
+0.35%
854.57855.71859.45855.71
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.40%
217.73
+0.86
+0.40%
216.87216.87217.76216.17
SIXT
Technology
SIXT
Technology
SIXT
+1.45%
3,613.68
+51.74
+1.45%
3,561.943,571.443,620.243,562.15
SIXU
Utilities
SIXU
Utilities
SIXU
+0.00%
903.33
+0.020
+0.00%
903.31903.26906.56901.88
SIXV
Health care
SIXV
Health care
SIXV
+0.26%
1,485.32
+3.78
+0.26%
1,481.541,482.481,488.461,474.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.31%
2,407.31
+7.36
+0.31%
2,399.952,404.452,412.722,398.09
PRME:NASDAQ
Prime Medicine, Inc
$3.20
-2.14%
(-0.070) 1D
May 14, 11:15:01 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRME...
Open
$3.30
High
$3.35
Low
$3.12
Mkt. cap
582.49M
Avg. vol.
2.01M
Volume
676.15K
52-wk high
$6.94
52-wk low
$1.11
EPS
-$1.26
Beta
2.35
Shares outstanding
180.62M
No. of employees
146
News stories
From sources across the web
Yahoo Finance
Yahoo Finance
·
1 day ago
Prime Medicine (PRME) Reports Q1 EPS
Profile
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts. Wikipedia
About Prime Medicine, Inc
CEO-
Employees146
Founded2019
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.12M
1.22M
838.00K
856.00K
Cost of goods sold
3.22M
43.99M
34.71M
34.10M
Cost of revenue
3.22M
43.99M
34.71M
34.10M
Research and development expenses
38.16M
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.12M
11.21M
14.74M
17.40M
Operating expense
51.27M
11.21M
14.74M
17.40M
Total operating expenses
54.49M
55.20M
49.45M
51.51M
Operating income
-53.38M
-53.97M
-48.61M
-50.65M
Other non operating income
18.00K
44.00K
49.00K
51.00K
EBT including unusual items
-52.59M
-50.58M
-46.08M
-49.12M
EBT excluding unusual items
-52.62M
-52.79M
-47.48M
-49.58M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-52.59M
-50.58M
-46.08M
-49.12M
Net profit margin
-4,716.68%
-4,129.14%
-5,498.69%
-5,738.55%
Earnings per share
-0.41
-0.32
-0.24
-0.28
Interest and investment income
743.00K
1.14M
1.08M
1.02M
Interest expense
-
-
-
-
Net interest expenses
743.00K
1.14M
1.08M
1.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
-51.51M
-52.09M
-46.73M
-48.80M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more